Search
29/04/2022
Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
Barguilla, I, Unzueta, U, Carratala, JV, Cano-Garrido, O, Villaverde, A, Hernandez, A, Ferrer-Miralles, N. Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells. Frontiers in Bioengineering and Biotechnology. 2022; 10DOI:10.3389/fbioe.2022.842256. PMID:35573225. IF:5.700(Q1/3D).
27/04/2022
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Rodriguez, N, Gasso, P, Martinez-Pinteno, A, Segura, AG, Mezquida, G, Moreno-Izco, L, Gonzalez-Penas, J, Zorrilla, I, Martin, M, Rodriguez-Jimenez, R, Corripio, I, Sarro, S, Ibanez, A, Butjosa, A, Contreras, F, Bioque, M, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Mas, S, Amoretti, SS, Moren, C, Stella, C, Gurriaran, X, Alonso-Solis, A, Grasa, E, Fernandez, J, Gonzalez-Ortega, I, Casanovas, F, Bulbuena, A, Nunez-Doyle, A, Jimenez-Rodriguez, O, Pomarol-Clotet, E, Feria-Raposo, I, Usall, J, Munoz-Samons, D, Ilundain, JL, Sanchez-Torres, AM, Saiz-Ruiz, J, Lopez-Torres, I, Nacher, J, De-la-Camara, C, Gutierrez, M, Saiz, PA. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00215-1. PMID:35853879. IF:5.400(Q2/3D).
26/04/2022
Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
Ruiz-Barrio, I, Horta-Barba, A, Illan-Gala, I, Kulisevsky, J, Pagonabarraga, J. Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.861585. PMID:35557621. IF:3.400(Q2/5D).
25/04/2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
Muller, RU, Messchendorp, AL, Birn, H, Capasso, G, Cornec-Le Gall, E, Devuyst, O, van Eerde, A, Guirchoun, P, Harris, T, Hoorn, EJ, Knoers, NVAM, Korst, U, Mekahli, D, Le Meur, Y, Nijenhuis, T, Ong, ACM, Sayer, JA, Schaefer, F, Servais, A, Tesar, V, Torra, R, Walsh, SB, Gansevoort, RT. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(5)DOI:10.1093/ndt/gfab312. PMID:35134221. IF:6.100(Q1/2D).